July 1998

Everyone involved seems to be grappling with ethical issues arising from the Human Genome Program. The science is still in flux.
What's a doctor to do when her patients embrace the untried and outlandish — sometimes with their insurers' blessings?
Doreen R. Orion, M.D.
HMOs can miss the mark for a lot of reasons. But health care experts say it's difficult to pin a scarlet letter on a health plan.
Frank Diamond
Michael D. Dalzell
Medicare beneficiaries could gain a lot from managed care, and so could health plans. But it's not all that easy.
Peter Wehrwein
FACCT's president talks about the need for patients to take charge of their health care and the challenges of developing a set of quality measures for children.